Bajaj Healthcare Limited (NSE:BAJAJHCARE) — Market Cap & Net Worth
Market Cap & Net Worth: Bajaj Healthcare Limited (BAJAJHCARE)
Bajaj Healthcare Limited (NSE:BAJAJHCARE) has a market capitalization of $120.06 Million (Rs11.10 Billion) as of August 10, 2026. Listed on the NSE stock exchange, this India-based company holds position #18530 globally and #998 in its home market, demonstrating a 0.72% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bajaj Healthcare Limited's stock price Rs329.80 by its total outstanding shares 33662661 (33.66 Million). See BAJAJHCARE capital expenditure intensity to understand how much of operating cash flow is reinvested back into capital assets.
Bajaj Healthcare Limited Market Cap History: 2021 to 2026
Bajaj Healthcare Limited's market capitalization history from 2021 to 2026. Data shows change from $149.29 Million to $120.06 Million (-1.83% CAGR).
Bajaj Healthcare Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bajaj Healthcare Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Bajaj Healthcare Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.76x
Bajaj Healthcare Limited's market cap is 0.76 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $149.29 Million | $6.56 Billion | $831.09 Million | 0.02x | 0.18x |
| 2022 | $161.06 Million | $6.79 Billion | $713.86 Million | 0.02x | 0.23x |
| 2023 | $136.52 Million | $6.46 Billion | $430.24 Million | 0.02x | 0.32x |
| 2024 | $208.75 Million | $4.73 Billion | -$837.93 Million | 0.04x | N/A |
| 2025 | $151.12 Million | $5.43 Billion | $394.95 Million | 0.03x | 0.38x |
| 2026 | $120.06 Million | $6.11 Billion | $157.66 Million | 0.02x | 0.76x |
Competitor Companies of BAJAJHCARE by Market Capitalization
Companies near Bajaj Healthcare Limited in the global market cap rankings as of August 10, 2026.
Key companies related to Bajaj Healthcare Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #529 globally with a market cap of $50.98 Billion USD ( CN¥348.42 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #556 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #627 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #529 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.98 Billion | CN¥54.62 |
| #556 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $44.91 |
| #627 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €14.90 |
Bajaj Healthcare Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Bajaj Healthcare Limited's market cap moved from $149.29 Million to $ 120.06 Million, with a yearly change of -1.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs120.06 Million | -20.55% |
| 2025 | Rs151.12 Million | -27.61% |
| 2024 | Rs208.75 Million | +52.90% |
| 2023 | Rs136.52 Million | -15.24% |
| 2022 | Rs161.06 Million | +7.88% |
| 2021 | Rs149.29 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 10th, 2026 the market cap of Bajaj Healthcare Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $120.06 Million USD |
| MoneyControl | $120.06 Million USD |
| MarketWatch | $120.06 Million USD |
| marketcap.company | $120.06 Million USD |
| Reuters | $120.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Bajaj Healthcare Limited
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anti-diabetic, antibiotic, … Read more